Cystatin C and eGFR <sub>CKD-EPI-CysC</sub> : novel biomarkers for renal impairment diagnosis and two-year progression-free survival in multiple myeloma-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Cystatin C and eGFR _CKD-EPI-CysC : novel biomarkers for renal impairment diagnosis and two-year progression-free survival in multiple myeloma

Published:2023-12 Issue:8 Volume:83 Page:599-603
ISSN:0036-5513
Container-title:Scandinavian Journal of Clinical and Laboratory Investigation
language:en
Short-container-title:Scandinavian Journal of Clinical and Laboratory Investigation

Author:

Niu Jian¹,Yu Jiajia¹,Huang Huifang¹,Shi Jinfang¹,Zheng Dong¹^ORCID,Qiu Jun¹

Affiliation:

1. Center of Clinical Laboratory, the First Affiliated Hospital of Soochow University, Suzhou, China

Funder

Foundation of Engineering Research Center of Drug Technology for Diagnosis and Treatment of Blood and Vascular Diseases, Ministry of Education

Publisher

Informa UK Limited

Subject

Clinical Biochemistry,General Medicine

Link

https://www.tandfonline.com/doi/pdf/10.1080/00365513.2023.2297364

Reference21 articles.

1. Expert consensus for the diagnosis and treatment of patients with renal impairment of multiple myeloma;Renal Impairment of Multiple Myeloma Collaborative Study Group;Chin J Intern Med,2017

2. Clinical features and treatment outcome of elderly multiple myeloma patients with impaired renal function

3. Current Trends of Renal Impairment in Multiple Myeloma

4. Lack of Renal Recovery Predicts Poor Survival in Patients of Multiple Myeloma With Renal Impairment

5. How to use… serum creatinine, cystatin C and GFR

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP